Antiviral compounds

A compound selected from:

• Ethyl 2-[3-(benzoylamino)benzoylamino]benzoate
• 2-[[3-(Benzoylamino)benzoyl]amino]benzoic acid
• Ethyl 2-[4-(benzoylamino)benzoylamino]benzoate
• 2-[2-(Acetylamino)benzoylamino]benzoic acid
• 2-[2-(Trimethylacetylamino)benzoylamino]benzoic acid
• 2-[[2-(Cyclohexanecarboxylamino)benzoyl]amino]benzoic acid
• 2-[2-(4-Carboxybutanoylamido)benzoyl]aminobenzoic acid
• 2-[2-(Benzylamino)benzoylamino]benzoic acid
• 2-[2-(2-Fluorobenzoylamino)-benzoylamino]benzoic acid
• 2-[2-(3-Fluorobenzoylamino)-benzoylamino]benzoic acid
• 2-[2-(4-Fluorobenzoylamino)-benzoylamino]benzoic acid
• Ethyl 2-[2-(benzoylamino)benzoylamino]benzoate
• Ethyl 2-[2-(acetylamino)benzoylamino]benzoate
• Ethyl 2-[2-(trimethylacetylamino)benzoylamino]benzoate
• Ethyl 2-[[2-(cyclohexanecarboxylamino)benzoyl]amino]benzoate
• Ethyl 2-[2-(phenylacetylamino)benzoylamino]benzoate
• Ethyl 2-[2-(4-carboxybutanoylamido)benzoyl]aminobenzoate
• Ethyl 2-[[2-(benzylamino)benzoyl]amino]benzoate
• 2-[[2-(Benzoylamino)benzoyl]amino]benzoic acid
• 2-[2-(Acetylamino)benzoylamino]benzoic acid
• 2-[2-(Trimethylacetylamino)benzoylamino]benzoic acid
• 2-[[2-(Cyclohexanecarboxylamino)benzoyl]amino]benzoic acid
• 2-[2-(Phenylacetylamino)benzoylamino]benzoic acid
• 2-[2-(4-Carboxybutanoylamido)benzoyl]aminobenzoic acid
• 2-[2-(Benzylamino)benzoylamino]benzoic acid
• 2-[2-(benzoylamino)benzoylamino]phenylacetic acid
• 2-[2-(benzoylamino)phenylacetylamino]benzoic acid
• 2-[2-(2-fluorobenzoylamino)-benzoylamino]-4-chlorobenzoic acid
• 2-[2-(2-fluorobenzoylamino)benzoylamino]-5-chlorobenzoic acid
• 2-[2-(2-fluorobenzoylamino)-benzoylamino]-4-methoxybenzoic acid
• 2-[2-(2-fluorobenzoylamino)-benzoylamino]-5-methoxybenzoic acid
• 2-[2-(2-fluorobenzoylamino)-benzoylamino]-4,5-difluorobenzoic acid
• 2-[4-chloro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid
• 2-[5-chloro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid
• 2-[4-methoxy-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid
• 2-[5-methoxy-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, and
• 2-[4,5-difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid
• or a pharmaceutically acceptable salt thereof.

A method for the prophylaxis or treatment of a viral disease, the method comprising administering a therapeutically effective amount of a compound of the general formula (I), (II) or (III) or a pharmaceutical acceptable salt thereof to a subject in need of such treatment:

• wherein X1 is selected from —CO—NH—, —NH—,
• X2 is CO—NH—,
• A is selected from the group consisting of, hydrogen, —C1-8alkyl, —C2-8alkenyl, —C2-8alkynyl, —(CH2)nC3-7cycloalkyl, —(CH2)nC2-9heterocycloalkyl, —(CH2)nphenyl, —(CH2)n naphthyl, —(CH2)naryl, —(CH2)nheteroaryl, —(CH2)nNR6R6, —(CH2)nN(R6)CO2C1-8alkyl, —(CH2)nCO2H, —(CH2)nCO2C1-8alkyl,
• wherein alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, phenyl, naphthyl, heteroaryl, and (CH2) are unsubstituted or substituted with one to three substituents independently selected from halogen, oxo, nitro, hydroxy, —NR6R6, —CN, —CF3, —OCF3,
• —C1-6alkyl, —C2-6 alkenyl, —C2-6 alkynyl, —C1-6 alkyloxy;
• R1 is selected from hydrogen, halogen, nitro, hydroxy, —CO2H, —CO2C1-4alkyl, —C1-6alkyl, —C2-6 alkenyl, —C2-6 alkynyl, —C1-6 alkyloxy, —CN, —CF3, —OCF3, tetrazol-5-yl, —CONR6R6;
• R2, R3, R4 and R5 are each independently selected from hydrogen, halogen, oxo, nitro, hydroxy, —NR6R6, —CN, —CF3, —OCF3, —C1-6 alkyl, —C2-6 alkenyl, —C2-6 alkynyl,
• —C1-6 alkyloxy;
• each R6 is independently selected from the group consisting of hydrogen, —C1-8alkyl, —C2-8alkenyl, —C2-8alkynyl, —(CH2)nCO2H;
• and
• n is 0, 1, 2, 3, 4, or 5.